Google's AMIE graduates to The Lancet: prospective diagnostics in a real clinic
From the AI digest for 2026-10-12
What happened: Sundar Pichai and Demis Hassabis announced The Lancet published the AMIE study run with BIDMC Medicine — the first prospective study of patient-facing conversational diagnostics in a real clinic, and Google's first-ever paper in The Lancet's main journal (Pichai's post Oct 8, ~6:50 PM ET; Hassabis's congrats RT Oct 12, ~9:09 PM ET). AMIE is a research system people chat with before doctors' appointments; in real urgent-care testing, clinicians reported the summaries helped them prepare for visits in 75% of cases and influenced their approach to care in more than half, and AMIE's differential diagnoses matched the doctors' final diagnoses 90% of the time.
What's genuinely new: A debut storyline on the record: clinical AI validated through prospective peer-reviewed publication rather than a consumer launch. It is the institutional twin of the ai-prescribing thread (Nolla's Utah pilot, oversight loosening by design) — same access-to-diagnosis lane, opposite evidence culture. The 90% match and the >half "influenced care" figure are the numbers that make this news-bearing rather than vendor PR.
Watch: Any product surface beyond "research system"; independent clinical read-outs; whether the prescribing thread's looser-oversight arc and AMIE's regulated-publication arc converge or stay separate. Links: Pichai/Hassabis — the AMIE study in The Lancet · Hassabis — congrats on the milestone